{
  "retracted": false,
  "timestamp": 1476662400000,
  "updates": [
    {
      "timestamp": 1585253759792,
      "identifier": {
        "doi": "10.1007/s10147-016-1052-3"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10147-016-1039-0"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer"
}
